Compliance to oral bisphosphonate therapy similar regardless of follow-up type
Compliance and persistence to oral bisphosphonate therapy following initiation within a secondary fracture prevention program: a randomised controlled trial of specialist vs. non-specialist managementOsteoporos Int. 2014 Apr;25(4):1345-55. doi: 10.1007/s00198-013-2610-4. Epub 2014 Jan 21.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
102 patients with incident osteoporotic fractures were initiated on oral bisphosphonate therapy within a secondary fracture prevention program with subsequent management by either a specialist (Group A) or a primary care physician (Group B). Compliance and persistence to oral bisphosphonate therapy was determined over 2 years. Compliance and persistence were high, and did not significantly differ ...
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.Continue